Table 2.
Mortality (age, cause, and association with comorbidities)
| Parameter | Treatment not Started (n = 5) |
Treatment Withdrawal (n = 7) |
Actively Treated (n = 16) |
|||
|---|---|---|---|---|---|---|
| With Comorbidities | Without Comorbidities | With Comorbidities | Without Comorbidities | With Comorbidities | Without Comorbidities | |
| Number | 1 | 4 | 6 | 1 | 10 | 6 |
| Age at death | ||||||
| <6 mo | 0 | 4 | 4 | 1 | ||
| 6 mo to 1 yr | 1 | 0 | 1 | 1 | 1 | |
| 1 to 2 yr | 1 | 3 | 2 | |||
| 2 to 5 yr | 1 | 2 | ||||
| 5 to 10 yr | 1 | 1 | ||||
| 10 to 15 yr | 1 | |||||
| 15 to 20 yr | 1 | |||||
| >20 yr | 1 | |||||
| Modality of treatment at death | ||||||
| conservative | 2 | 2 | ||||
| PD | 5 | 1 | 4 | 1 | ||
| HD | 1 | 2 | ||||
| Transplant | 4 | 1 | ||||
| Cause of death | ||||||
| cot death | 2 | 3 | ||||
| sepsis | 3 | 1 | ||||
| mesenteric infarct/GI hemorrhage | 1 | 1 | ||||
| pulmonary edema | 1 | |||||
| hyperkalemia | 1 | |||||
| PTLD | 3 | |||||
GI, gastrointestinal; PTLD, posttransplantation lymphoproliferative disease.